<DOC>
	<DOCNO>NCT00554450</DOCNO>
	<brief_summary>The purpose study assess effect dapagliflozin renal glucose clearance type 2 diabetic subject mild , moderate , severe renal impairment compare type 2 diabetic healthy subject normal renal function</brief_summary>
	<brief_title>Renal Impairment Type 2 Diabetic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Key Subjects follow group : Group A : Healthy Subjects Normal Renal Function ( CLcr &gt; 80 mL/min ) Group B : Diabetic Subjects Normal Renal Function ( CLcr &gt; 80 mL/min ) Group C : Diabetic Subjects Mild Renal Impairment ( CLcr &gt; 50 ≤80 mL/min ) Group D : Diabetic Subjects Moderate Renal Impairment ( CLcr ≥ 30 ≤50 mL/min ) Group E : Diabetic Subjects Severe Renal Impairment ( CLcr &lt; 30 mL/min ) ( receive dialysis ) Men WOCBP , age 18 79 year old Standard Exclusion Criteria , plus : History diabetic ketoacidosis HbA*1c &gt; 10 % Serum albumin &lt; 2.0 gm/dL Potassium &lt; 3.0 &gt; 6.0 mEq/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>